Notification

🚨 Trading Holiday 🚨

The NSE and BSE will remain closed for trading and settlement on Monday, April 14, 2025, on account of Dr. B. R. Ambedkar Jayanti.

Open a Free Demat Account

Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.

Trade Now, Pay Later with up to 4x

Never miss a good trading opportunity due to low funds with our MTF feature.

Track Market Movers Instantly

Stay updated with real-time data. Get insights at your fingertips.

NSE BSE

Trade Nowopens in a new tab

Td Power Systems Ltd. Share Price

₹ 431.65 22.89 (5.60%)

Apr 15 2025 03:30 PM Capital Goods - Electrical Equipment NSE: TDPOWERSYS

Td Power Systems Ltd. Share Price Update

As of the latest trading session, Td Power Systems Ltd. share price is currently at 431.65, which is up by 22.89 from its previous closing. Today, the stock has fluctuated between 414.80 and 434.65. Over the past year, Td Power Systems Ltd. has achieved a return of 41.14 %. In the last month alone, the return has been 20.87 %. Read More...

Td Power Systems Ltd. Performance

Day Range

Low414.80 High434.65

431.65

52 Week Range

Low 276.75 High 482.85

431.65

Td Power Systems Ltd. Share Price

25178

533553

TDPOWERSYS

Compare to down-arrow

View

Display

Studies

No Data Available

Open Price

417.15 Prev. Close

408.75 Volume (Shares)

631987.00

Total traded value

2727.97

Upper Circuit

490.50 Lower Circuit

327.00

Note: The current prices & values are delayed, Loginopens in a new tab to your account for live updates.

Td Power Systems Ltd. Fundamentals

(Standalone)

Market Cap (Cr)	6741.08
PE Ratio (TTM)	44.21
Book Value / Share	48.91
Beta	1.57

ROE	19.18%
EPS (TTM)	9.26
Dividend Yield	0.27%
Net Profit Qtr (Cr)	37.18

Td Power Systems Ltd. Financials

Key Results
Key Ratios
Balance sheet
Cash Flow
Competition

Revenue

Net income

Particulars	DEC 2024 (Values in Cr)
Revenue	321.01
Operating Expense	274.26
Net Profit	37.18
Net Profit Margin (%)	11.58
Earnings Per Share (EPS)	2.38
EBITDA	55.73
Effective Tax Rate (%)	26.50

Particulars	SEP 2024 (Values in Cr)
Revenue	304.45
Operating Expense	255.55
Net Profit	40.63
Net Profit Margin (%)	13.34
Earnings Per Share (EPS)	2.60
EBITDA	60.98
Effective Tax Rate (%)	26.64

Particulars	JUN 2024 (Values in Cr)
Revenue	263.58
Operating Expense	223.92
Net Profit	31.94
Net Profit Margin (%)	12.11
Earnings Per Share (EPS)	2.05
EBITDA	48.05
Effective Tax Rate (%)	24.86

Particulars	MAR 2024 (Values in Cr)
Revenue	267.84
Operating Expense	228.83
Net Profit	34.88
Net Profit Margin (%)	13.02
Earnings Per Share (EPS)	2.23
EBITDA	52.29
Effective Tax Rate (%)	25.61

Particulars	DEC 2023 (Values in Cr)
Revenue	230.36
Operating Expense	198.95
Net Profit	28.66
Net Profit Margin (%)	12.44
Earnings Per Share (EPS)	1.84
EBITDA	43.53
Effective Tax Rate (%)	25.26

Particulars	MAR 2024 (Values in Cr)
Revenue	983.88
Operating Expense	840.92
Net Profit	124.18
Net Profit Margin (%)	12.62
Earnings Per Share (EPS)	7.95
EBITDA	187.14
Effective Tax Rate (%)	25.42

Particulars	MAR 2023 (Values in Cr)
Revenue	821.48
Operating Expense	723.56
Net Profit	88.46
Net Profit Margin (%)	10.76
Earnings Per Share (EPS)	5.70
EBITDA	140.12
Effective Tax Rate (%)	25.92

Particulars	MAR 2022 (Values in Cr)
Revenue	718.81
Operating Expense	662.57
Net Profit	54.41
Net Profit Margin (%)	7.56
Earnings Per Share (EPS)	17.68
EBITDA	97.09
Effective Tax Rate (%)	26.26

Particulars	MAR 2021 (Values in Cr)
Revenue	499.41
Operating Expense	488.58
Net Profit	17.48
Net Profit Margin (%)	3.50
Earnings Per Share (EPS)	5.73
EBITDA	48.95
Effective Tax Rate (%)	25.68

Particulars	MAR 2020 (Values in Cr)
Revenue	478.94
Operating Expense	477.67
Net Profit	16.44
Net Profit Margin (%)	3.43
Earnings Per Share (EPS)	5.36
EBITDA	46.03
Effective Tax Rate (%)	11.57

Particulars	MAR 2024 (Values in Cr)
Book Value / Share	45.15
ROE %	18.07
ROCE %	25.12
Total Debt to Total Equity	0.00
EBITDA Margin	18.71

Particulars	MAR 2023 (Values in Cr)
Book Value / Share	38.76
ROE %	17.11
ROCE %	22.09
Total Debt to Total Equity	0.06
EBITDA Margin	17.74

Particulars	MAR 2022 (Values in Cr)
Book Value / Share	170.33
ROE %	14.13
ROCE %	17.55
Total Debt to Total Equity	0.12
EBITDA Margin	15.20

Particulars	MAR 2021 (Values in Cr)
Book Value / Share	153.92
ROE %	8.80
ROCE %	11.43
Total Debt to Total Equity	0.13
EBITDA Margin	13.48

Particulars	MAR 2020 (Values in Cr)
Book Value / Share	140.05
ROE %	4.55
ROCE %	5.75
Total Debt to Total Equity	0.15
EBITDA Margin	9.79

Particulars	MAR 2024 (Values in Cr)
Book Value / Share	44.89
ROE %	19.18
ROCE %	26.02
Total Debt to Total Equity	0.00
EBITDA Margin	19.36

Particulars	MAR 2023 (Values in Cr)
Book Value / Share	38.08
ROE %	15.85
ROCE %	20.64
Total Debt to Total Equity	0.06
EBITDA Margin	17.45

Particulars	MAR 2022 (Values in Cr)
Book Value / Share	168.89
ROE %	10.88
ROCE %	14.23
Total Debt to Total Equity	0.12
EBITDA Margin	14.14

Particulars	MAR 2021 (Values in Cr)
Book Value / Share	155.13
ROE %	3.76
ROCE %	6.12
Total Debt to Total Equity	0.13
EBITDA Margin	10.67

Particulars	MAR 2020 (Values in Cr)
Book Value / Share	149.58
ROE %	3.28
ROCE %	4.82
Total Debt to Total Equity	0.14
EBITDA Margin	9.88

Particulars	MAR 2024 (Values in Cr)
Cash & Short Term Investments	211.36
Total Assets	1037.81
Total Liabilities	1037.81
Total Equity	705.13
Share Outstanding	156170101
Price to Book Ratio	6.60
Return on Assets (%)	11.40
Return on Capital (%)	16.78

Particulars	MAR 2023 (Values in Cr)
Cash & Short Term Investments	169.26
Total Assets	903.21
Total Liabilities	903.21
Total Equity	604.51
Share Outstanding	156042635
Price to Book Ratio	4.16
Return on Assets (%)	10.71
Return on Capital (%)	16.01

Particulars	MAR 2022 (Values in Cr)
Cash & Short Term Investments	161.34
Total Assets	906.69
Total Liabilities	906.69
Total Equity	527.16
Share Outstanding	31103498
Price to Book Ratio	2.04
Return on Assets (%)	7.77
Return on Capital (%)	11.79

Particulars	MAR 2021 (Values in Cr)
Cash & Short Term Investments	164.30
Total Assets	784.87
Total Liabilities	784.87
Total Equity	470.67
Share Outstanding	30933414
Price to Book Ratio	0.95
Return on Assets (%)	5.75
Return on Capital (%)	8.65

Particulars	MAR 2020 (Values in Cr)
Cash & Short Term Investments	158.20
Total Assets	757.42
Total Liabilities	757.42
Total Equity	425.00
Share Outstanding	30933414
Price to Book Ratio	0.57
Return on Assets (%)	3.95
Return on Capital (%)	6.08

Particulars	MAR 2024 (Values in Cr)
Cash & Short Term Investments	189.50
Total Assets	1012.26
Total Liabilities	1012.26
Total Equity	701.11
Share Outstanding	156170101
Price to Book Ratio	6.60
Return on Assets (%)	12.26
Return on Capital (%)	17.71

Particulars	MAR 2023 (Values in Cr)
Cash & Short Term Investments	151.57
Total Assets	869.97
Total Liabilities	869.97
Total Equity	593.89
Share Outstanding	156042635
Price to Book Ratio	4.16
Return on Assets (%)	10.16
Return on Capital (%)	14.89

Particulars	MAR 2022 (Values in Cr)
Cash & Short Term Investments	144.41
Total Assets	883.09
Total Liabilities	883.09
Total Equity	522.65
Share Outstanding	31103498
Price to Book Ratio	2.04
Return on Assets (%)	6.14
Return on Capital (%)	9.14

Particulars	MAR 2021 (Values in Cr)
Cash & Short Term Investments	154.63
Total Assets	758.95
Total Liabilities	758.95
Total Equity	474.42
Share Outstanding	30933414
Price to Book Ratio	0.95
Return on Assets (%)	2.30
Return on Capital (%)	3.32

Particulars	MAR 2020 (Values in Cr)
Cash & Short Term Investments	140.37
Total Assets	749.34
Total Liabilities	749.34
Total Equity	454.47
Share Outstanding	30933414
Price to Book Ratio	0.57
Return on Assets (%)	2.19
Return on Capital (%)	3.15

Particulars	MAR 2024 (Values in Cr)
Net Income	162.20
Cash from Operations	122.51
Cash from Investing	-32.59
Cash from Financing	-15.69
Net change in Cash	34.04
Free Cash Flow	163.15

Particulars	MAR 2023 (Values in Cr)
Net Income	129.54
Cash from Operations	124.27
Cash from Investing	-10.40
Cash from Financing	-89.12
Net change in Cash	-13.30
Free Cash Flow	140.26

Particulars	MAR 2022 (Values in Cr)
Net Income	92.07
Cash from Operations	28.01
Cash from Investing	-5.24
Cash from Financing	10.88
Net change in Cash	7.96
Free Cash Flow	39.22

Particulars	MAR 2021 (Values in Cr)
Net Income	56.48
Cash from Operations	6.93
Cash from Investing	-8.21
Cash from Financing	-19.71
Net change in Cash	-33.34
Free Cash Flow	18.58

Particulars	MAR 2020 (Values in Cr)
Net Income	32.76
Cash from Operations	63.91
Cash from Investing	0.05
Cash from Financing	-16.64
Net change in Cash	39.19
Free Cash Flow	77.25

Particulars	MAR 2024 (Values in Cr)
Net Income	166.51
Cash from Operations	109.43
Cash from Investing	-25.06
Cash from Financing	-15.69
Net change in Cash	30.82
Free Cash Flow	149.88

Particulars	MAR 2023 (Values in Cr)
Net Income	119.41
Cash from Operations	116.39
Cash from Investing	-7.03
Cash from Financing	-89.12
Net change in Cash	-14.06
Free Cash Flow	132.30

Particulars	MAR 2022 (Values in Cr)
Net Income	73.79
Cash from Operations	6.83
Cash from Investing	-1.39
Cash from Financing	10.88
Net change in Cash	0.70
Free Cash Flow	14.86

Particulars	MAR 2021 (Values in Cr)
Net Income	23.51
Cash from Operations	6.48
Cash from Investing	-5.73
Cash from Financing	-19.70
Net change in Cash	-25.18
Free Cash Flow	16.98

Particulars	MAR 2020 (Values in Cr)
Net Income	18.58
Cash from Operations	49.88
Cash from Investing	5.58
Cash from Financing	-16.64
Net change in Cash	31.07
Free Cash Flow	60.07

Company Name	Price	P/E	P/B	Market Cap	52 Week Low/High
CG POWER AND IND SOL LTD	572.40	93.07	24.88	87512.49	479.80 / 874.50
JYOTI LTD.	82.11	13.71	-3.41	189.61	60.00 / 165.00
KAYCEE INDUSTRIES LTD.	1050.60	60.14	24.70	333.41	350.00 / 4897.15
MODERN INSULATORS LTD.	99.94	11.86	1.05	471.16	89.70 / 176.00

Company Name	Price	P/E	P/B	Market Cap	52 Week Low/High
BHARAT BIJLEE LTD	2879.50	24.68	1.47	3254.73	2372.60 / 5700.80
CG POWER AND IND SOL LTD	572.40	93.07	23.48	87512.49	479.80 / 874.50
GE VERNOVA T&D INDIA LTD	1332.95	69.93	24.79	34130.18	861.00 / 2215.70
ABB INDIA LIMITED	5140.85	58.11	15.39	108938.92	4590.05 / 9200.00

Technicals

EMA & SMA
Resistance and Support
Price Change Analysis

Bullish Moving Averages -

Bearish Moving Averages -

5 Days 393.60
26 Days 380.00
10 Days 391.60
50 Days 376.50
12 Days 390.30
100 Days 382.90
20 Days 383.70
200 Days 378.40

403.98
PIVOT

First Resistance	415.27
Second Resistance	421.78
Third Resistance	433.07

First Support	397.47
Second Support	386.18
Third Support	379.67

RSI	58.51
MACD	10.33
Commodity Channel Index (CCI)	57.71

ADX	36.82
Williams % R	-22.57

Td Power Systems Ltd. Future

Future: Price

25 May

0 100 200 300 400 500 600

Discount/Premium

25 May

0 1 2 3 4 5 6 7

Active Calls

25 May

0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul

0 500 1000 1500 2000 2500

Stock Holding

View Live Stock Screeners

Holding

Public

21.03 Promoter Holdings

34.26 FII

17.79 DII

26.9 Promoter Shares(Pledge Percentage)

0.0

Name	Category	Shares	Shares%
Saphire Finman Services Llp	Shareholding of Promoter and Promoter Group	2.3958225E7	15.34
Nikhil Kumar	Shareholding of Promoter and Promoter Group	1.746532E7	11.18
Nippon Life India Trustee Ltd-a/c Nippon India Small Cap Fund	Public Shareholding	1.2558235E7	8.04
Hitoshi Matsuo	Shareholding of Promoter and Promoter Group	1.0040486E7	6.43
Aditya Birla Sun Life Trustee Private Limited A/c Aditya Birla Sun Life Small Cap Fund	Public Shareholding	7403222.0	4.74
Oxbow Master Fund Limited	Public Shareholding	6478110.0	4.15
Hdfc Mutual Fund - Hdfc Multi Cap Fund	Public Shareholding	5169391.0	3.31
Goldman Sachs Funds - Goldman Sachs India Equity Portfolio	Public Shareholding	4859611.0	3.11
The Master Trust Bank Of Japan, Ltd. As Trustee Of Hsbc India Infrastructure Equity Mother Fund	Public Shareholding	3200000.0	2.05
Mirae Asset Aggressive Hybrid Fund	Public Shareholding	2989344.0	1.91
Hsbc Multi Cap Fund	Public Shareholding	2870851.0	1.84
Lic Mf Multi Cap Fund	Public Shareholding	2604072.0	1.67
Uti- Infrastructure Fund	Public Shareholding	1989408.0	1.27
Sundaram Mutual Fund A/c Sundaram Small Cap Fund	Public Shareholding	1815317.0	1.16
Matthews India Fund	Public Shareholding	1812823.0	1.16
Lavanya Sankaran	Shareholding of Promoter and Promoter Group	1700000.0	1.09
Aarya Sankaran Kumar	Shareholding of Promoter and Promoter Group	273530.0	0.18
Sagir Mohib Khericha	Shareholding of Promoter and Promoter Group	80000.0	0.05
Chartered Capital & Investment Ltd	Shareholding of Promoter and Promoter Group	0.0	0.0
Sofia Mohib Khericha	Shareholding of Promoter and Promoter Group	0.0	0.0
Mohib Nomanbhai Khericha	Shareholding of Promoter and Promoter Group	0.0	0.0

Td Power Systems Ltd.

Ex-Date	Dividend Amt.	Dividend Type	Record Date	Instrument Type
2023-11-22	0.5	Interim	2023-11-22	Equity shares	2023-08-02	0.5	Final	2023-08-02	Equity shares	2023-02-20	0.5	Interim	2023-02-20	Equity shares	2022-09-19	3.5	Final	2022-09-20	Equity shares	2021-09-16	2.5	Final	2021-09-17	Equity shares	2020-09-17	0.75	Final	2020-09-18	Equity shares	2020-02-24	1.5	Interim	2020-02-25	Equity shares	2019-08-01	2.0	Final	2019-08-02	Equity shares	2018-09-18	1.8	Final	2018-09-21	Equity shares	2017-09-19	1.8	Final	2017-09-21	Equity shares	2016-09-14	3.05	Final	2016-09-16	Equity shares	2015-09-15	2.64	Final	2015-09-17	Equity shares	2014-08-01	2.3	Final	2014-08-05	Equity shares	2013-09-11	2.0	Final	2013-09-13	Equity shares	2012-07-05	2.0	Final	2012-07-07	Equity shares

Learn More About Stocks

Dr Reddy’s Denies Workforce Reduction Claims Amid Cost-Cut Rumours

Dr Reddy’s Laboratories rejects claims of reducing workforce costs by 25%, asserting no such plans or internal directives.

15 Apr, 2025 | 3 Min. read

Glenmark, Sun Pharma, Zydus Recall Drugs in US over Compliance Issues

Glenmark, Sun Pharma, and Zydus recall multiple drug batches in the US following manufacturing deviations and contamination concerns as per USFDA enforcement reports.

15 Apr, 2025 | 3 Min. read

HAL Denies Selecting PwC for R&D Benchmarking Amid Ongoing Bids

HAL clarifies no consultancy firm has been finalised for R&D benchmarking amid social media buzz about PwC. Selection process still ongoing via GeM portal.

15 Apr, 2025 | 3 Min. read

Aurobindo Pharma Gets USFDA Nod for Generic Xarelto 2.5mg Tablets

Aurobindo Pharma receives USFDA approval to launch generic Xarelto 2.5mg in Q1 FY26, targeting $447 million US market; higher strengths also gain tentative nod.

15 Apr, 2025 | 3 Min. read

IndiGo Becomes World’s Most Valuable Airline With $23.4 Billion Market Cap

IndiGo surpasses global peers to become the most valuable airline by market cap at $23.4 billion, pushing InterGlobe Aviation share price to record highs in 2025.

11 Apr, 2025 | 3 Min. read

SRF Ltd. Commissions New Agrochemical Unit in Dahej Worth Rs.239 Crore

SRF Ltd. starts new agrochemical facility in Dahej, Gujarat with Rs.239 crore investment. Phase 1 operational, full commissioning set for April 2025.

11 Apr, 2025 | 3 Min. read

Tata Motors’ JLR India Achieves Record Sales in FY25 at 6,183 Units

JLR India posts record-breaking FY25 retail sales of 6,183 units, up 40%. Defender leads growth, boosting Tata Motors share price sentiment.

11 Apr, 2025 | 4 Min. read

Biocon Gets USFDA Approval for Jobevne, Expands Oncology Portfolio

Biocon Biologics receives USFDA nod for cancer drug Jobevne, a bevacizumab biosimilar. Oncology portfolio in US grows, boosting Biocon Ltd. share price outlook.

11 Apr, 2025 | 3 Min. read